MedCity News

Orchestra BioMed’s Hypertension Device Wins FDA Breakthrough Designation

CRISPR Biotech Caribou Trims Pipeline and Cuts 32% of Staff to Focus on Two Cancer Cell Therapies

Caribou Biosciences’ restructuring narrows the biotech’s focus to two off-the-shelf cell therapies for blood cancers, whose key data readouts have been pushed out to the second half of 2025. It’s the CRISPR-editing company’s second cash-saving restructuring in the past year.

By Frank Vinluan

MedCity Influencers

Agentic AI and the Architecture of Healthcare Transformation

We need intelligent, scalable systems that lift burdens, illuminate connections, and empower healthcare professionals to deliver their highest-quality care. Agentic AI provides this essential capability.

By Ganesh Padmanabhan

MedCity Influencers

Community-Driven Digital Solutions Can Transform Addiction Treatment and Ease the Burden on the Healthcare System

Technology has the power to revolutionize treatment, make it more widely available, provide additional patient insight, and ultimately, alleviate the strain on our already stressed healthcare system.

By Traci Sweet

Latest News

Health Tech, Startups

Nourish Lands $70M to Fight Chronic Disease with Nutrition Care

Nourish's Series B round was led by J.P. Morgan Private Capital’s Growth Equity Partners. In total, the company has raised $115 million.

By Marissa Plescia

Consultants: Help Define What’s Next In Healthcare Benefits

Help shape the future of healthcare benefits by sharing your insights.

By MedCity News

Startups

Trial Data Shows ‘IUD for Men’ Is Effective for 2 Years

Contraline released promising new trial data showing that its male contraceptive gel has demonstrated safety and efficacy in the first two trial participants to reach the two-year mark. The company is aiming to earn the product’s FDA approval by the end of 2028, according to CEO Kevin Eisenfrats.

By Katie Adams

BioPharma, Startups

Aiming for Earlier Intervention, Flagship Startup Etiome Emerges to Define ‘Biostages’ of Disease

Etiome’s precision medicine approach introduces a temporal component to treating disease — drugs developed specifically to treat disease at particular points in time even before symptoms show. The Flagship Pioneering startup’s approach offers the potential to prevent disease; in cases where disease is already present, Etiome aims to halt or even reverse it.

By Frank Vinluan

BioPharma

MedCity Pivot: What if Pancreatic Cancer Became a Chronic Disease?

Ben Zeskind, co-founder, president and CEO of Immuneering, is attempting a new approach to treat certain types of cancers. If it works, there will be a vast improvement in the quality of life of cancer patients.

By Arundhati Parmar

Changes in Nurse Staffing Answer Clinician Demands

The ongoing nursing shortage facilitates high turnover rates since nurses know they won’t have difficulties finding new jobs. In order to retain and attract staff, it’s in a facility’s best interest to understand what nurses want.

By Tomasz Rezik

MedCity Influencers

How Health Insurers Are Embracing Technology to Serve Real People

The time to innovate is now. By embracing transformative solutions, insurers and employers can not only address systemic challenges but also create a future where healthcare is equitable and sustainable.

By Brad Otto

MedCity Influencers

Advancing Patient & Planet Health Through Proper Healthcare Waste Management

By prioritizing sustainability-minded and compliant waste management in the workplace, healthcare leaders can advance patient and employee well-being, as well as environmental and fiscally responsible programs.

By Alex Chapman

Tackling Rising Drug Costs and Growing Popularity of GLP-1’s

See how Quantum Health is providing the steps to help their members tackle the cost of specialty medications and other drugs.

By Quantum Health and MedCity News

There’s a Gap Between Healthcare Leaders’ AI Confidence and Their Ability to Scale

Healthcare leaders might be too confident about their AI readiness, according to new research. It showed that 70% of leaders feel at least somewhat confident in their organization’s AI governance frameworks, but only 15% report having scalable infrastructure in place.

By Katie Adams

Consumer / Employer, Health Tech

World Class Health Secures $10M for Global Centers of Excellence Network

World Class Health's $10 million raise was led by Transformation Capital. It comes six months after the company secured $8 million in seed funding.

By Marissa Plescia

BioPharma, Pharma

Bristol Myers Squibb Schizophrenia Drug Fails Pivotal Test as an Add-On to Antipsychotics

Bristol Myers Squibb’s Cobenfy failed to outdistance a placebo in a Phase 3 test that evaluated the drug as an adjunct to antipsychotics in schizophrenia patients. Last September, the FDA approved Cobenfy as a standalone schizophrenia treatment.

By Frank Vinluan

MedCity Influencers

Improving Patient Trust with Digital Communication

Patients need tailored touchpoints throughout their health journey to stay engaged with their care plan. To do this effectively, healthcare organizations must leverage technology and digital communication strategies to drive and retain patient engagement and experience end-to-end.

By Bob Farrell

MedCity Influencers

How Leveraging Information for Action can Build a More Sustainable Healthcare System

By aligning incentives and encouraging collaboration across sectors, we can build a resilient system that adapts to changing needs and delivers value to all stakeholders.

By Bartley Bryt

Health Tech

Free Market Health Acquires Beeline Rx to Streamline Specialty Prior Auth

Free Market Health acquired Beeline Rx, a tech company that streamlines the prior authorization process for specialty drugs.

By Marissa Plescia